Lucid Diagnostics Inc (LUCD) Financials

$0.94

$-0.01 (-1.23%)

As on 04-Sep-2026 16:00EDT

Market cap

$179 Mln

Revenue (TTM)

$5 Mln

P/E Ratio

--

P/B Ratio

17.3

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	5.45	4.71	4.35	2.43	0.38	0.50
Cost of Revenue	6.85	7.54	8.27	8.48	3.61	0.59
Gross Profit	-1.40	-2.84	-3.92	-6.05	-3.24	-0.09
Operating Expenses	49.28	46.80	42.13	42.43	52.93	27.33
Operating Profit (EBIT)	-50.69	-49.64	-46.05	-48.48	-56.17	-27.42
Other Income	--	--	--	--	--	--
Profit before Tax	-52.26	-58.01	-45.53	-52.67	-56.17	-28.08
Provision for Tax	12,747.00	12,559.00	7,496.00	2.33	1.71	0.66
Profit after Tax (Net Income)	-52.26	-58.01	-45.53	-52.67	-56.17	-28.08
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-56.17	-28.08

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	10.93	10.94	5.39	-2.31	23.05	54.74
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	0.50	0.93	1.80	0.20	1.04	1.49
Current Liabilities	27.52	28.58	23.52	29.38	8.43	4.26
Total Liabilities	66.46	40.45	30.72	27.27	32.51	59.00

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	2.32	2.98	5.57	5.20	8.15	1.70
Current Assets	36.62	37.47	25.15	22.07	24.36	57.30
Total Assets	75.57	40.45	30.72	27.27	32.51	59.00
Total Debt*	24.91	25.82	21.25	15.26	2.00	--
Net Current Assets	--	8.89	1.62	-7.31	15.93	53.04

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-46.49	-44.14	-32.82	-29.69	-17.67
Cash Flow from Investing Activities	--	-0.20	-0.65	-0.22	-4.11	-0.86
Cash from Financing Activities	--	59.03	48.25	29.46	2.61	72.08
Net Cash Inflow / Outflow	--	--	--	--	-31.18	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-0.46	-0.57	-0.79	-1.26	-1.50	-0.80
Cash EPS ($)	--	-0.56	-0.77	-1.20	-1.45	-0.80
Adjusted Book Value ($)	--	0.11	0.09	--	0.62	1.57
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.46	-0.76	-0.79	-0.80	-0.51
Free Cash Flow per Share ($)	--	-0.46	-0.78	-0.79	-0.82	-0.53

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-182.99	-230.01	-277.26	-140.81	-136.23
ROE (%)	-478.06	-710.60	-2,956.43	-507.97	-144.42	-136.23
ROA (%)	-72.75	-163.04	-157.04	-176.20	-122.77	-91.77
EBIT Margin (%)	-959.43	-1,232.21	-1,047.01	-2,151.98	-14,897.35	-5,483.80
Net Margin (%)	-959.76	-1,232.68	-1,047.61	-2,169.11	-14,899.47	-5,615.60
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	24.89	0.08	0.79	5.44	-0.25	--
EBIT Growth (%)	5.42	-27.44	12.91	6.97	-104.83	-231.17
Net Profit Growth (%)	5.43	-27.41	13.55	6.24	-100.05	-239.13
EPS Growth (%)	48.28	0.28	0.37	0.16	-0.87	-2.59
Book Value Growth (%)	-24.87	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-1.92	-1.04	-1.12	-0.90	-6.68
Price / Book Value	17.28	10.16	8.76	-25.48	2.20	3.43
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-0.67	-1.79	-1.04	-1.11	-0.53	-4.84
Close Price ($)	1.07	1.09	0.82	1.41	1.36	5.37
High Price ($)	1.63	1.80	1.58	1.85	5.53	13.52
Low Price ($)	0.90	0.78	0.63	1.04	1.15	4.61
Market Cap ($ Cr)	179.40	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	2.36	3.94	-6.60	0.09	--
Short term debt to equity ratio	2.23	2.28	3.61	-6.51	0.04	--
Current Ratio	1.33	1.31	1.07	0.75	2.89	13.45
Quick Ratio	1.31	1.30	1.05	0.74	2.88	13.34
Interest Coverage	-2,902.28	-2,635.82	-1,750.12	-125.60	-7,020.38	-41.61

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	19.98	13.66	9.32	1.85	4.51	40.00
Asset Turnover	0.08	0.13	0.15	0.08	0.01	0.02
Receivable days	--	40.67	18.91	4.66	105.12	73.05
Inventory Days	--	16.80	13.68	8.38	30.52	414.26
Payable days	--	53.54	52.74	47.43	128.66	1,107.61
Cash Conversion Cycle	--	3.94	-20.15	-34.39	6.98	-620.30

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.